TMC Life Sciences Berhad
0101
Rank in Stocks
#17133
TMC Life Sciences Berhad operates as an investment holding entity, specializing... TMC Life Sciences Berhad operates as an investment holding entity, specializing in the provision of healthcare services throughout Malaysia. Its primary asset is Thomson Hospital Kota Damansara (THKD), a substantial 559-bed medical facility located in Selangor. THKD delivers a comprehensive spectrum of medical specialties, including orthopedics, ear, nose, and throat (ENT) care, head and neck laser procedures, dedicated services for women and children, fertility treatments, dietetic guidance, and emergency care. The company's fertility centers offer advanced reproductive technologies such as time-lapse imaging, preimplantation genetic testing, and fertility genecode analysis, alongside expert consultancy services. Beyond its main hospital operations, TMC Life Sciences manages a network of women's clinics and fertility centers, provides laboratory and embryology services, traditional and complementary medicine, and operates pharmacy outlets. Its activities further extend to developing and marketing healthcare programs, offering multi-disciplinary tertiary care support, engaging in research and development initiatives, and undertaking property investments. Established in 1994 and based in Petaling Jaya, Malaysia, the company is a subsidiary of Sasteria (M) Pte. Ltd.
Share Price
$0.10349928
Last synced: 2026-11-10
Market Cap
$180.28M
Change (1 day)
0.00%
Change (1 year)
-0.38%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TMC Life Sciences Berhad (0101)
Category
Healthcare
EPS for TMC Life Sciences Berhad (0101)
EPS as of June 2026 TTM: $0.00
According to TMC Life Sciences Berhad's latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for TMC Life Sciences Berhad from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -89.80% |
| 2025 | 0.00 | -89.80% |
| 2024 | 0.00 | 2.08% |
| 2023 | 0.00 | -11.11% |
| 2022 | $0.01 | 92.86% |
| 2021 | 0.00 | 33.33% |
| 2020 | 0.00 | -27.59% |
| 2019 | 0.00 | -25.64% |
| 2018 | 0.00 | 11.43% |
| 2017 | 0.00 | 66.67% |
| 2016 | 0.00 | -25.00% |
| 2015 | 0.00 | 12.00% |
| 2014 | 0.00 | -44.44% |
| 2013 | 0.00 | -255.17% |
| 2012 | 0.00 | -84.97% |
| 2011 | $-0.02 | 394.87% |
| 2009 | 0.00 | -316.67% |
| 2008 | 0.00 | -88.00% |
| 2007 | $0.02 | 5.63% |
| 2006 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $30.27 | 1,210,700.00% |
US
|
|
| $3.19 | 127,476.00% |
DE
|
|
| $34.71 | 1,388,300.00% |
US
|
|
| $1.90 | 75,988.00% |
SA
|
|
| $0.29 | 11,420.00% |
CN
|
Questions about TMC Life Sciences Berhad's earnings per share (EPS)
What is TMC Life Sciences Berhad's earnings per share (EPS)?
TMC Life Sciences Berhad's earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was TMC Life Sciences Berhad's earnings per share (EPS) in 2025?
In 2025, TMC Life Sciences Berhad's earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has TMC Life Sciences Berhad's earnings per share (EPS) changed since 2020?
From 2020 to 2025, TMC Life Sciences Berhad's earnings per share (EPS) was highest in 2022 ($0.01) and lowest in 2025 (0.00).
How does TMC Life Sciences Berhad's earnings per share (EPS) compare with similar companies?
TMC Life Sciences Berhad's earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is Tenet Healthcare Corporation, with $34.71.